Evidence-Based Complementary and Alternative Medicine / 2020 / Article / Tab 3

Research Article

Fortified S-Allyl L-Cysteine: Animal Safety, Effect on Retinal Ischemia, and Role of Wnt in the Underlying Therapeutic Mechanism

Table 3

The effect on electroretinogram b-wave amplitudes (mV) changes after oral gavage for 4 weeks of preischemia daily doses of SAC or Vehicle treatment.

Time/groupVehicleSAC 0.18 mgSAC 0.018 mgSAC 0.0018 mg

Baseline0.43 ± 0.030.41 ± 0.050.48 ± 0.060.41 ± 0.07
Week 10.49 ± 0.050.44 ± 0.050.44 ± 0.060.45 ± 0.06
Week 20.43 ± 0.070.37 ± 0.060.46 ± 0.100.47 ± 0.08
Week 30.41 ± 0.070.35 ± 0.040.44 ± 0.060.40 ± 0.01
Week 40.35 ± 0.040.38 ± 0.050.44 ± 0.030.41 ± 0.04

The ERG amplitudes of a- and b-waves were recorded at the baseline (0 week) or 1/2/3/4 weeks after oral gavage of daily doses of vehicle or SAC (0.18, 0.018, or 0.0018 mg). The results are recorded without following ischemia and represented as mean ± S.E.M. (n = 6∼11). ERG, electroretinogram; SAC, S-allyl L-cysteine.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.